{
    "DATE": "18-MAR-1987 08:59:49.97",
    "TOPICS": [
        "earn"
    ],
    "PLACES": [
        "usa"
    ],
    "NEWID": "6438",
    "TEXT": {
        "TITLE": "COOPERVISION <EYE> DELAYS ANNUAL MEETING",
        "DATELINE": "    PALO ALTO, Calif., March 18 - ",
        "BODY": "CooperVision Inc said it has\ndelayed its annual meeting to June 22 from May 14 to allow its\nboard to review possible recapitalization options before the\nmeeting.\n    CooperVision today reported first quarter net income of\n64.6 mln dlrs, after a 175.2 mln dlr pretax gain from the sale\nof its ophthalmic business to Johnson and Johnson <JNJ> for 260\nmln dlrs in cash and a 17.9 mln dlr posttax charge from a debt\nrepurchase.  Sales were 94.4 mln dlrs.  A year earlier it\nearned 7,300,000 dlrs after a 120,000 dlr loss from\ndiscontinued operations, on sales of 85.4 mln dlrs.\n    The company said an aggressive program of investment\nspending to maintain or increase market shares its its two core\nbusinesses will accelerate sales growth this year but hold back\nincreases in operating income in the near future.\n    CooperVision said \"Furthermore, until the entire net cash\nproceeds from the recent sales of several of our businesses are\nemployed to reduce indebtedness, make strategic acquisitions\nand/or are otherwise employed in relation to a possible\nrecapitalization of the company, recovery of net income will be\nheld back by the loss, particularly of the tax income, of the\n(ophthalmic) pharmaceutical business sold to Johnson and\nJohnson.\"\n Reuter\n\u0003"
    },
    "ORGS": [
        "icco"
    ],
    "PEOPLE": [
        "lawson"
    ],
    "EXCHENGES": [
        "liffe",
        "cbt"
    ]
}